Regulatory Research Priorities for AI Use in the Medicine Lifecycle: A European Perspective with Global Relevance.
- DOI
- 10.1002/cpt.70400
- Published
- 2026 Aug 13
- Container
- Clinical pharmacology and therapeutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cpt.70400,
title = {Regulatory Research Priorities for AI Use in the Medicine Lifecycle: A European Perspective with Global Relevance.},
author = {Pinheiro LC and Langston AC and Orre M and Zinserling J and Boumaki K and Hornung BVH and O'Sullivan S and Westman G and Broich K and Arlett P},
year = {2026},
journal = {Clinical pharmacology and therapeutics},
doi = {10.1002/cpt.70400},
url = {https://doi.org/10.1002/cpt.70400}
}RIS
TY - JOUR TI - Regulatory Research Priorities for AI Use in the Medicine Lifecycle: A European Perspective with Global Relevance. AU - Pinheiro LC AU - Langston AC AU - Orre M AU - Zinserling J AU - Boumaki K AU - Hornung BVH AU - O'Sullivan S AU - Westman G AU - Broich K AU - Arlett P PY - 2026 JO - Clinical pharmacology and therapeutics DO - 10.1002/cpt.70400 UR - https://doi.org/10.1002/cpt.70400 ER -
APA
LC, P., AC, L., M, O., J, Z., K, B., BVH, H., S, O., G, W., K, B., & P, A. (2026). Regulatory Research Priorities for AI Use in the Medicine Lifecycle: A European Perspective with Global Relevance.. Clinical pharmacology and therapeutics. https://doi.org/10.1002/cpt.70400
Source records
- pubmed · retrieved 2026-09-25T16:19:17.863Z